A sodium phosphate, tribasic, dodecahydrate CEP of the European Pharmacopoeia monograph is often referred to as a sodium phosphate, tribasic, dodecahydrate Certificate of Suitability (COS). The purpose of a sodium phosphate, tribasic, dodecahydrate CEP is to show that the European Pharmacopoeia monograph adequately controls the purity of sodium phosphate, tribasic, dodecahydrate EP produced by a given manufacturer. Suppliers of raw materials can prove the suitability of sodium phosphate, tribasic, dodecahydrate to their clients by showing that a sodium phosphate, tribasic, dodecahydrate CEP has been issued for it. The manufacturer submits a sodium phosphate, tribasic, dodecahydrate CEP (COS) as part of the market authorization procedure, and it takes on the role of a sodium phosphate, tribasic, dodecahydrate CEP holder for the record. Additionally, the data presented in the sodium phosphate, tribasic, dodecahydrate CEP (COS) is managed confidentially and offers a centralized system acknowledged by numerous nations, exactly like the sodium phosphate, tribasic, dodecahydrate DMF.
A sodium phosphate, tribasic, dodecahydrate CEP (COS) is recognised by all 36 nations that make up the European Pharmacopoeia Convention. sodium phosphate, tribasic, dodecahydrate CEPs may be accepted in nations that are not members of the Ph. Eur. at the discretion of the authorities there.
click here to find a list of sodium phosphate, tribasic, dodecahydrate suppliers with CEP (COS) on PharmaCompass.